Xarelto Mass Tort Lawsuits In Philadelphia, PA Sees Lawsuit Volume Increases
December 10, 2015 – – BloodThinnerHelp.com announces additional developments showing an increase in the lawsuits filed against anticoagulant Xarelto in Philadelpha, Pennsylvania’s mass tort group. This group was created following a motion to consolidate the mounting cases, which are said to have surpassed 500. Federally, these cases are joined by over 1,800 Xarelto bleeding lawsuit cases consolidated with multidistrict litigation number 2592 in the Eastern District of Louisiana. Plaintiffs involved in each case grouping similarly allege that blood-thinner Xarelto can cause serious uncontrollable bleeding episodes.
Litigation for the Xarelto cases is currently in initial pretrial and discovery stages. Those involved expect that as they await trial, these numbers will only continue to grow. Philadelphia’s mass tort cases were consolidated in the Philadelphia Court of Common Pleas, specifically in their Complex Litigation Center. Allegations within the suits are filed against defendants Bayer AG and Janssen Pharmaceuticals, (a subdivision of Johnson & Johnson). Additional claims state that these manufacturers were negligent to release their drug to the market without any corresponding antidote.
Many plaintiffs additionally note the fact that Xarelto was released to the market without any corresponding antidote. Due to this fact, they consider it the most dangerous blood thinner currently on the market. Without an antidote, individuals who are bleeding with Xarelto in their system will be unable to get their blood to clot. In these situations, physicians must result to extreme life-saving measures such as surgeries or blood transfusions.
The lawsuits currently filed in Philadelphia’s mass tort group cite multiple complaints, some of which include internal bleeding and wrongful death. Several of the suits have been filed by families of the victims, as the victims have passed away from uncontrollable bleeding episodes. Plaintiffs are seeking compensation for a range of things, from damages and medical bills to funeral costs and legal fees.
As these case numbers are expected to continue to grow, Attorney Joseph Osborne is currently working to help ensure that individuals involved are all given the opportunity to explore their legal rights. Anyone who has taken Xarelto and has suffered adverse health events that they attribute to the drug may be entitled to significant compensation. Attorney Osborne offers complimentary legal consultations to those affected.
For questions regarding this press release, or to request additional information about the pending Xarelto litigation, please contact Joseph Osborne, Esq. by calling (866) 425-8902.
###
Contact BloodThinnerHelp.com:
Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432
ReleaseID: 60006203